↓ Skip to main content

Dove Medical Press

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

Overview of attention for article published in OncoTargets and therapy, September 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
2 X users
patent
12 patents

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
138 Mendeley
Title
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
Published in
OncoTargets and therapy, September 2018
DOI 10.2147/ott.s135157
Pubmed ID
Authors

David D Stenehjem, Dao Tran, Michael A Nkrumah, Shilpa Gupta

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 138 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 11%
Researcher 14 10%
Student > Master 13 9%
Student > Ph. D. Student 10 7%
Student > Doctoral Student 8 6%
Other 24 17%
Unknown 54 39%
Readers by discipline Count As %
Medicine and Dentistry 37 27%
Biochemistry, Genetics and Molecular Biology 17 12%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Nursing and Health Professions 4 3%
Immunology and Microbiology 4 3%
Other 11 8%
Unknown 59 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#7,050,597
of 25,385,509 outputs
Outputs from OncoTargets and therapy
#355
of 3,016 outputs
Outputs of similar age
#115,199
of 345,739 outputs
Outputs of similar age from OncoTargets and therapy
#25
of 147 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,739 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.